Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
China Patent Application CN103,695,506 (A) Additional information Maximilian Schmacht and Eric Lorenz have contributed equally to this article
Key Insights for 2026 $1516 Billion Estimated global obesity drug market size $10.1 Billion GLP-1 obesity drug segment alone $105+ Billion Projected market by 2030 Blockbuster Drugs Leading the Market Wegovy (Semaglutide) Novo Nordisk Mounjaro / Zepbound (Tirzepatide) Eli Lilly Ozempic Novo Nordisk Major Market Trends GLP-1 drugs revolutionizing weight management Increased physician adoption and patient demand Entry of generics and new combination therapies Intensifying competition between pharma giants Indias Opportunity Indias obesity drug market has grown rapidly and is expected to cross $1 billion in the coming years, driven by new drug launches, increasing obesity rates, and rising awareness of metabolic health
This dual mechanism can lead to improved muscle recovery, enhanced muscle hypertrophy, and increased overall muscle mass
Urine mercury levels correlate with DNA methylation of imprinting gene H19 in the sperm of reproductive-aged men
US$ 27.66
US$ 22.10
US$ 28.90
US$ 22.09
US$ 27.23
US$ 26.39
US$ 29.51
